Jersey Shore Ready ...
Health Care: Drugs
Chembio Diagnostics Inc. (CEMI: NASDAQ)
$4.50 0.00 | 0.00%
05/24/13 - 03:59 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 2.95M | 3.01M | 2.14M | 1.07M |
| Receivables | 4.82M | 3.00M | 3.95M | 1.78M |
| Inventories | 2.49M | 2.30M | 1.35M | 1.56M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 11.01M | 8.99M | 7.64M | 4.67M |
| Property, Plant & Equipment, Gross | 3.71M | 3.29M | 2.70M | 2.20M |
| Accumulated Depreciation & Depletion | 2.28M | 2.23M | 1.89M | 1.62M |
| Property, Plant & Equipment, Net | 1.43M | 1.06M | 813.21K | 580.21K |
| Intangibles | 400.00K | 500.00K | 600.00K | 700.00K |
| Other Non-Current Assets | 265.56K | 182.26K | 36.23K | 367.94K |
| Total Non-Current Assets | 6.33M | 6.49M | 1.45M | 1.65M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 17.34M | 15.49M | 9.09M | 6.32M |
| Accounts Payable | 1.69M | 1.26M | 2.06M | 662.74K |
| Short Term Debt | 51.24K | 68.13K | 955.51K | 906.14K |
| Other Current Liabilities | 23.22K | 11.52K | 0.00 | 0.00 |
| Total Current Liabilities | 3.38M | 2.86M | 3.08M | 3.17M |
| Long Term Debt | 82.25K | 133.48K | 186.20K | 14.93K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 82.25K | 133.48K | 200.77K | 54.20K |
| Total Liabilities | 3.46M | 2.99M | 3.28M | 3.23M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 13.87M | 12.49M | 5.81M | 3.09M |
| Common Par | 80.36K | 633.68K | 622.39K | 619.80K |
| Additional Paid In Capital | 41.12M | 40.12M | 39.66M | 39.45M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -27.32M | -28.26M | -34.47M | -36.99M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 13.96M | 12.63M | 6.00M | 3.10M |
| Total Equity | 13.87M | 12.49M | 5.81M | 3.09M |
| Total Liabilities & Stock Equity | 17.34M | 15.49M | 9.09M | 6.32M |
| Total Common Shares Outstanding | 8.04M | 63.37M | 7.78M | 7.75M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 7.99M | 7.87M | 7.76M | 7.74M |
| Diluted Weighted Shares Outstanding | 8.61M | 8.56M | 8.87M | 9.38M |
| Number of Employees | 174 | 137 | 115 | 103 |
| Number of Part-Time Employees | 0 | 3 | 3 | 1 |
Portfolios with CEMI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
Latest CEMI Headlines from TheStreet
- Chembio Awarded $750,000 Cooperative Research Agreement 05.23.13 | 08:05 am
- Chembio Appoints Sharon Klugewicz As Chief Operating Officer 05.22.13 | 04:05 pm
- Chembio Enters International Distribution And Assembly Agreement With Labtest 05.21.13 | 08:05 am
- Chembio Sponsors 28th Annual AIDS Walk New York As Co-Chair Advocate 05.17.13 | 08:05 am
- Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor For Development Of Rapid, Point-of-Care Influenza Immunity Test 05.16.13 | 08:05 am
- Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity And Specificity In Evaluation By Mexico's Institute Of Epidemiological Diagnosis And Reference 05.14.13 | 09:05 am
- Chembio Diagnostics Reports First Quarter 2013 Financial Results 05.09.13 | 08:05 am
- Chembio Diagnostics Supports Recent USPSTF Routine Testing Recommendations 05.02.13 | 09:05 am
- Chembio To Host Conference Call To Discuss First Quarter 2013 Financial Results 04.25.13 | 08:04 am
- Chembio Commences CLIA Waiver Studies For DPP(R) HIV 1/2 Assay 04.18.13 | 08:04 am
Press Releases for CEMI
- Chembio Diagnostics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.06.12 | 10:02 am
- Chembio Presenting At Biotech Conference - PR Newswire 01.09.12 | 08:01 am
- Chembio Provides Business Update - PR Newswire 01.03.12 | 08:01 am
- Chembio To Host Conference Call To Discuss 3rd Quarter 2011 Financial Results - PR Newswire 10.20.11 | 08:10 am
- Chembio Diagnostics' CFO Richard J. Larkin Among The Recipients Of "2011 CFO Of The Year" Award From Long Island Business News - PR Newswire 08.18.11 | 08:08 am
- Chembio To Host Conference Call To Discuss 2nd Quarter 2011 Financial Results - PR Newswire 07.20.11 | 08:07 am
- Chembio To Sponsor AIDS Walk New York 2011 - PR Newswire 05.11.11 | 08:05 am
- Chembio Corrects Previous Press Release - PR Newswire 04.21.11 | 05:04 pm
- Chembio Files PMA Module With FDA For DPP® HIV Test - PR Newswire 04.19.11 | 08:04 am
Partner Headlines for CEMI
- Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 06:08 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 03:08 pm
- Med-tech Companies to Watch in 2012 - Analyst Blog - Zacks 01.09.12 | 07:01 am
- Q1 2011 Financial Results... - Analyst Blog - Zacks 05.06.11 | 09:05 am
- Major Milestone for Chembio - Analyst Blog - Zacks 07.01.10 | 06:07 pm
- Chembio Diagnostics Inc. - Bull of the Day - Zacks 06.22.10 | 01:06 am
